SCHEMBL30852252

SCHEMBL30852252

OCc1ncccc1C1CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PDK2 Q15119 1/20 0.42
HTR1A P08908 5/20 0.37
SLC6A2 P23975 4/20 0.37
SLC6A4 P31645 4/20 0.37
SLC6A3 Q01959 2/20 0.37
SSTR4 P31391 2/20 0.37
CXCR4 P61073 1/20 0.37
ABL1 P00519 1/20 0.36
CYP2C19 P33261 2/20 0.36
CYP1A2 P05177 1/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21942819 1.00 ALDH1A1 (0.52) ALDH1A1L3MBTL1PDK2HTR1ASLC6A2
SCHEMBL2083835 0.91 ALDH1A1 (0.47) ALDH1A1L3MBTL1PDK2CYP2C19HIF1A
SCHEMBL30851646 0.82 PDK2 (0.44) ALDH1A1L3MBTL1PDK2HTR1ASLC6A2
SCHEMBL17778193 0.81 PDK2 (0.42) ALDH1A1L3MBTL1PDK2HTR1ASLC6A2
SCHEMBL12059248 0.81 PDK2 (0.42) PDK2HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL29586612 0.81 PDK2 (0.42) ALDH1A1L3MBTL1PDK2HTR1ASLC6A2
SCHEMBL24485234 0.80 HTR1A (0.40) PDK2HTR1ASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL4799073 0.79 PDK2 (0.41) ALDH1A1L3MBTL1PDK2HTR1ASLC6A2
SCHEMBL15677609 0.78 PDK2 (0.41) PDK2HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL13310539 0.77 SSTR4 (0.40) PDK2HTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed